ID
15394
Description
Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025); ODM derived from: https://clinicaltrials.gov/show/NCT01668784
Link
https://clinicaltrials.gov/show/NCT01668784
Keywords
Versions (1)
- 5/29/16 5/29/16 -
Uploaded on
May 29, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma DRKS00006490 NCT01668784
Eligibility Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma NCT01668784
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
central nervous system (cns) metastases
Data type
boolean
Alias
- UMLS CUI [1]
- C0279130
Description
Sirolimus
Data type
boolean
Alias
- UMLS CUI [1]
- C0072980
Description
autoimmune disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0004364
Description
adrenal insufficiency
Data type
boolean
Alias
- UMLS CUI [1]
- C1963059
Description
chronic liver disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0341439
Description
Malignant Neoplasms
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826